Hybrid Oncology Safety & Risk Director

GSK; Durham (NC); Hybrid; USD 218,000 - 363,000; Full time

Job summary

GSK is seeking a Scientific Director to provide advanced safety evaluation and risk management leadership for oncology assets in clinical development. The role shapes safety strategy, leads cross‑functional collaboration, and ensures robust benefit‑risk profiles for patients globally.

The position emphasizes strategic safety planning, data interpretation, and proactive risk mitigation within a matrix environment, with hybrid UK/American collaboration and senior‑level governance exposure.

Qualifications

• Degree in a health or life sciences discipline (e.g., Bachelor of Science, PharmD, MD, PhD, or equivalent).
• 5+ years experience in pharmacovigilance, drug safety, or related safety evaluation role in the pharmaceutical or biotech industry.
• Practical experience in signal detection, safety surveillance and risk management across clinical development and post‑marketing.
• Knowledge of global pharmacovigilance requirements and drug development processes.
• Strong clinical or scientific judgement with experience interpreting clinical and safety data.

Responsibilities

• Lead pharmacovigilance activities and risk mitigation strategies for assigned oncology assets and clinical trials.
• Drive the evaluation and interpretation of safety data, including signal detection and assessment.
• Develop strategic approaches for safety issue evaluation within clinical development programs.
• Contribute to safety components of global regulatory submissions (e.g., INDs, DSURs, IBs).
• Perform literature review, clinical data synthesis, and integrated safety analyses to inform decision‑making.
• Ensure high‑quality, timely delivery of outputs while managing multiple priorities.

Skills

Digital Fluency

Enterprise Leadership

Influencing Without Authority

Pharmacovigilance

Presentation Techniques

Education

Bachelor's degree in health or life sciences

Advanced degree (PharmD, PhD, MD)

Job description

GSK is seeking a Scientific Director to provide advanced safety evaluation and risk management leadership for oncology assets in clinical development. The role shapes safety strategy, leads cross‑functional collaboration, and ensures robust benefit‑risk profiles for patients globally.

The position emphasizes strategic safety planning, data interpretation, and proactive risk mitigation within a matrix environment, with hybrid UK/American collaboration and senior‑level governance exposure.